A mass spectrometry imaging approach for investigating how drug‐drug interactions influence drug blood‐brain barrier permeability

No abstract is available for this paper.

• Publication year

  2018

• Venue

  NeuroImage

• Publication date

  2018-05-15

• Fields of study

  Medicine, Chemistry, Computer Science

• Identifiers
  DOI 10.1016/j.neuroimage.2018.01.013PMID 29329980
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Laser Desorption/Ionization Mass Spectrometric Imaging of Endogenous Lipids from Rat Brain Tissue Implanted with Silver Nanoparticles

  2017cited by this paper
• A CRISPR-Cas9 Generated MDCK Cell Line Expressing Human MDR1 Without Endogenous Canine MDR1 (cABCB1): An Improved Tool for Drug Efflux Studies.

  2017influential reference
• Faster, More Reproducible DESI-MS for Biological Tissue Imaging

  2017cited by this paper
• Simultaneous imaging of multiple neurotransmitters and neuroactive substances in the brain by desorption electrospray ionization mass spectrometry

  2016cited by this paper
• msIQuant--Quantitation Software for Mass Spectrometry Imaging Enabling Fast Access, Visualization, and Analysis of Large Data Sets.

  2016cited by this paper
• Visualizing spatial distribution of alectinib in murine brain using quantitative mass spectrometry imaging

  2016cited by this paper
• Atmospheric pressure MALDI mass spectrometry imaging of tissues and cells at 1.4-μm lateral resolution

  2016cited by this paper
• Online, Absolute Quantitation of Propranolol from Spatially Distinct 20- and 40-μm Dissections of Brain, Liver, and Kidney Thin Tissue Sections by Laser Microdissection-Liquid Vortex Capture-Mass Spectrometry.

  2016cited by this paper
• Complete Knockout of Endogenous Mdr1 (Abcb1) in MDCK Cells by CRISPR-Cas9.

  2016influential reference
• Molecular imaging with engineered physiology

  2016cited by this paper
• Imaging the impact of cyclosporin A and dipyridamole on P-glycoprotein (ABCB1) function at the blood-brain barrier: A [(11)C]-N-desmethyl-loperamide PET study in nonhuman primates.

  2016cited by this paper
• Mapping drug distribution in brain tissue using liquid extraction surface analysis mass spectrometry imaging.

  2015cited by this paper
• A balanced view of choroid plexus structure and function: Focus on adult humans.

  2015cited by this paper
• Histological analyses by matrix-assisted laser desorption/ionization-imaging mass spectrometry reveal differential localization of sphingomyelin molecular species regulated by particular ceramide synthase in mouse brains.

  2015cited by this paper
• Mass spectrometry imaging in drug development.

  2015cited by this paper
• Repeatability and reproducibility of desorption electrospray ionization-mass spectrometry (DESI-MS) for the imaging analysis of human cancer tissue: a gateway for clinical applications

  2015cited by this paper
• Mass spectrometry imaging of cassette-dosed drugs for higher throughput pharmacokinetic and biodistribution analysis.

  2014cited by this paper
• Mechanistic Understanding of Brain Drug Disposition to Optimize the Selection of Potential Neurotherapeutics in Drug Discovery

  2014cited by this paper
• Direct targeted quantitative molecular imaging of neurotransmitters in brain tissue sections.

  2014cited by this paper
• Coadministration of P-Glycoprotein Modulators on Loperamide Pharmacokinetics and Brain Distribution

  2014influential reference
• Mass Spectrometry Imaging, an Emerging Technology in Neuropsychopharmacology

  2014cited by this paper
• Cytochrome P450 Inhibitory Properties of Common Efflux Transporter Inhibitors

  2014cited by this paper
• Physiology of blood-brain interfaces in relation to brain disposition of small compounds and macromolecules.

  2013cited by this paper
• Transporters of the blood-brain and blood-CSF interfaces in development and in the adult.

  2013cited by this paper
• Transporter Studies in Drug Development: Experience to Date and Follow‐Up on Decision Trees From the International Transporter Consortium

  2013cited by this paper
• Tariquidar and Elacridar Are Dose-Dependently Transported by P-Glycoprotein and Bcrp at the Blood-Brain Barrier: A Small-Animal Positron Emission Tomography and In Vitro Study

  2013influential reference
• Cerebrospinal fluid secretion by the choroid plexus.

  2013cited by this paper
• Kinetic analysis of human and canine P-glycoprotein-mediated drug transport in MDR1-MDCK cell model: approaches to reduce false-negative substrate classification.

  2013cited by this paper
• Molecular imaging of drug transit through the blood-brain barrier with MALDI mass spectrometry imaging

  2013cited by this paper
• Localization and quantification of drugs in animal tissues by use of desorption electrospray ionization mass spectrometry imaging.

  2012cited by this paper
• Paxinos and Franklin's the Mouse Brain in Stereotaxic Coordinates

  2012cited by this paper
• imzML--a common data format for the flexible exchange and processing of mass spectrometry imaging data.

  2012cited by this paper
• Inclusive sharing of mass spectrometry imaging data requires a converter for all.

  2012cited by this paper
• Improving the prediction of the brain disposition for orally administered drugs using BDDCS.

  2012influential reference
• Novel mass spectrometry imaging software assisting labeled normalization and quantitation of drugs and neuropeptides directly in tissue sections.

  2012cited by this paper
• Quantitative mass spectrometry imaging of propranolol and olanzapine using tissue extinction calculation as normalization factor.

  2012cited by this paper
• Improved spatial resolution in the imaging of biological tissue using desorption electrospray ionization

  2012cited by this paper
• Brain Distribution and Bioavailability of Elacridar after Different Routes of Administration in the Mouse

  2012influential reference
• Measurement of Unbound Drug Exposure in Brain: Modeling of pH Partitioning Explains Diverging Results between the Brain Slice and Brain Homogenate Methods

  2011cited by this paper
• Quantitative Evaluation of the Impact of Active Efflux by P-Glycoprotein and Breast Cancer Resistance Protein at the Blood-Brain Barrier on the Predictability of the Unbound Concentrations of Drugs in the Brain Using Cerebrospinal Fluid Concentration as a Surrogate

  2011cited by this paper
• Imaging of Intact Tissue Sections: Moving beyond the Microscope*

  2011cited by this paper
• Desorption electrospray ionization mass spectrometry for lipid characterization and biological tissue imaging.

  2011cited by this paper
• Qualitative and quantitative MALDI imaging of the positron emission tomography ligands raclopride (a D2 dopamine antagonist) and SCH 23390 (a D1 dopamine antagonist) in rat brain tissue sections using a solvent-free dry matrix application method.

  2011cited by this paper
• Differences in the expression of endogenous efflux transporters in MDR1‐transfected versus wildtype cell lines affect P‐glycoprotein mediated drug transport

  2010cited by this paper
• Membrane transporters in drug development

  2010cited by this paper
• Fine Mapping the Spatial Distribution and Concentration of Unlabeled Drugs within Tissue Micro-Compartments Using Imaging Mass Spectrometry

  2010cited by this paper
• Structure and function of the blood-brain barrier.

  2010cited by this paper
• P-Glycoprotein Function at the Blood–Brain Barrier in Humans Can Be Quantified with the Substrate Radiotracer 11C-N-Desmethyl-Loperamide

  2010cited by this paper
• Human Brain Imaging and Radiation Dosimetry of 11C-N-Desmethyl-Loperamide, a PET Radiotracer to Measure the Function of P-Glycoprotein

  2009influential reference
• Drug interactions at the blood-brain barrier: fact or fantasy?

  2009cited by this paper
• Structure-brain exposure relationships in rat and human using a novel data set of unbound drug concentrations in brain interstitial and cerebrospinal fluids.

  2009influential reference
• Comparison of drug distribution images from whole-body thin tissue sections obtained using desorption electrospray ionization tandem mass spectrometry and autoradiography.

  2008cited by this paper
• On The Rate and Extent of Drug Delivery to the Brain

  2007cited by this paper
• Postretrieval propranolol disrupts a cocaine conditioned place preference

  2006cited by this paper
• Differential in Vivo Sensitivity to Inhibition of P-glycoprotein Located in Lymphocytes, Testes, and the Blood-Brain Barrier

  2006cited by this paper
• Mass Spectrometry Sampling Under Ambient Conditions with Desorption Electrospray Ionization

  2004cited by this paper
• Identification of cytochrome P450 isoforms involved in the metabolism of loperamide in human liver microsomes

  2004cited by this paper
• Principles and applicability of CSF sampling for the assessment of CNS drug delivery and pharmacodynamics.

  2004cited by this paper
• Rapid induction of P-glycoprotein expression by high permeability compounds in colonic cells in vitro: a possible source of transporter mediated drug interactions?

  2004cited by this paper
• Imaging mass spectrometry: A new technology for the analysis of protein expression in mammalian tissues

  2001cited by this paper
• Role of P-Glycoprotein in Restricting Propranolol Transport in Cultured Rabbit Conjunctival Epithelial Cell Layers

  2000cited by this paper
• Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS.

  1997cited by this paper
• Identification of human CYP isoforms involved in the metabolism of propranolol enantiomers--N-desisopropylation is mediated mainly by CYP1A2.

  1995cited by this paper
• THE DENSITY OF TISSUES IN AND ABOUT THE HEAD

  1970influential reference

• Advances in desorption electrospray ionization mass spectrometry imaging: Research progress and applications.

  2026cites this paper
• Innovative applications and future perspectives of chromatography-mass spectrometry in drug research

  2025cites this paper
• Preserving Neuronal Chemical Messengers: Heat Stabilization Versus Snap Freezing for Improved MALDI Mass Spectrometry Imaging of Brain Tissues

  2025cites this paper
• How can MSI enhance our understanding of ASO distribution?

  2024cites this paper
• Identification of New Ketamine Metabolites and Their Detailed Distribution in the Mammalian Brain

  2024cites this paper
• Advances in Ultra-High-Resolution Mass Spectrometry for Pharmaceutical Analysis

  2023cites this paper
• Pharmacokinetic considerations to optimize clinical outcomes for COVID-19 drugs

  2022cites this paper
• Advances in spatial mass spectrometry enable in-depth neuropharmacodynamics.

  2022cites this paper
• Method To Visualize the Intratumor Distribution and Impact of Gemcitabine in Pancreatic Ductal Adenocarcinoma by Multimodal Imaging.

  2022cites this paper
• Mass spectrometry imaging advances and application in pharmaceutical research

  2022cites this paper
• Spatiotemporally resolved metabolomics and isotope tracing reveal CNS drug targets

  2022cites this paper
• Mass spectrometry imaging: new eyes on natural products for drug research and development

  2022cites this paper
• Neuropharmacokinetic visualization of regional and subregional unbound antipsychotic drug transport across the blood–brain barrier

  2021cites this paper
• Desorption Electrospray Ionization Mass Spectrometry Imaging of Cimbi-36, a 5-HT2A Receptor Agonist, with Direct Comparison to Autoradiography and Positron Emission Tomography

  2021cites this paper
• Quantitative mass spectrometry imaging of drugs and metabolites: a multiplatform comparison

  2021cites this paper
• Integration of Mass Spectrometry Imaging and Machine Learning Visualizes Region-Specific Age-Induced and Drug-Target Metabolic Perturbations in the Brain

  2021cites this paper
• Desorption electrospray ionization mass spectrometry imaging in discovery and development of novel therapies.

  2021cites this paper
• Mass spectrometry imaging in drug distribution and drug metabolism studies – principles, applications and perspectives

  2021cites this paper
• A Critical and Concise Review of Mass Spectrometry Applied to Imaging in Drug Discovery

  2020cites this paper
• Quantitative MALDI Mass Spectrometry Imaging for Exploring Cutaneous Drug Delivery of Tofacitinib in Human Skin.

  2020cites this paper
• ADVANCES IN HIGH-RESOLUTION MALDI MASS SPECTROMETRY FOR NEUROBIOLOGY.

  2020cites this paper
• Building on the success of osimertinib: achieving CNS exposure in oncology drug discovery.

  2019cites this paper
• The Opportunities and Use of Imaging to Measure Target Engagement

  2019influential citation
• Neuropharmacokinetics: a bridging tool between CNS drug development and therapeutic outcome.

  2019cites this paper
• Tissue Imaging by Mass Spectrometry: A Practical Guide for the Medicinal Chemist.

  2019cites this paper
• Toward Higher Sensitivity in Quantitative MALDI Imaging Mass Spectrometry of CNS Drugs Using a Nonpolar Matrix.

  2018cites this paper
• Customer Insights Dr. Per Andrén

  2018cites this paper
• Delivery of amitriptyline by intravenous and intraperitoneal administration compared in the same animal by whole-body mass spectrometry imaging of a stable isotope labelled drug substance in mice

  2018cites this paper
• Targeted Drug and Metabolite Imaging: Desorption Electrospray Ionization Combined with Triple Quadrupole Mass Spectrometry

  2018cites this paper
• Blood brain barrier: A review of its anatomy and physiology in health and disease

  2018cites this paper